http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-289201-A5
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90f2f07b9cbb25e4d81bbbfb2f141418 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
| filingDate | 1989-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c57124cfcda1a68651ef8843270c685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e90bf44637b4d680125a98cfc8db39f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dedd47140bc545cbd4c8f9ba36f4408a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17c4390556e0ae88c4b2e16e80a0275f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14ff73be98b113549cdeb7dd4847eda3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cf06f98ee05533fe0318cabc3f8b73b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4baf4a53b5186febef357580222facf7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f0a37e2cfc46ee10e3d5fbf92351093 |
| publicationDate | 1991-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DD-289201-A5 |
| titleOfInvention | METHOD FOR PRODUCING AN IMMUNOMODULATING VACCINE AGAINST VIRUSES |
| abstract | The invention relates to a method for producing an immunomodulating vaccine against viruses. It relates to the production of a combination vaccine with intensified effect and high efficacy against viruses in the human and veterinary medical field. Essentially, the production of the combination vaccine is based on physiological, easily isolatable natural products in conjunction with viruses or viral components or even attentuierten viruses or genetically engineered bioproducts in the form of genetically engineered microorganisms. According to the invention, an extract is obtained from raw potatoes or wheat seedlings or other natural products, from which lectin is obtained as an immunomodulator by uncomplicated centrifugation and concentration steps. In lyophilized form, the glycoproteins with the antigen components mentioned are converted into enteric-coated oral vaccines or parenteral vaccines. In contrast to the production of vaccines without lectin, these preparations produce a highly effective preparation. {Bacteria; Gamma rays; glycoproteids; Immunomodulators; immunostimulants; inactivation; interferon inducers; potatoes; lectins; lyophilisates; Vaccine; viruses; Wheat} |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1635793-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6541001-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1635793-A4 |
| priorityDate | 1989-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 77.